insights_auto
Why is CYTK down 2,71%?
Dive Deeperchevron_right
CYTK:NASDAQ
Cytokinetics, Inc.
61,00 $
arrow_downward
-2,71%(-1,70) 1D
6 қаз., 13:37:06 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
62,20 $
High
62,52 $
Low
60,68 $
Mkt. cap
8,87 млрд
Avg. vol.
2,09 млн
Volume
1,30 млн
52-wk high
88,31 $
52-wk low
54,30 $
EPS
-7,22 $
Beta
0,41
Shares outstanding
139,02 млн
No. of employees
673
Open
62,20 $
High
62,52 $
Low
60,68 $
Mkt. cap
8,87 млрд
Avg. vol.
2,09 млн
Volume
1,30 млн
52-wk high
88,31 $
52-wk low
54,30 $
EPS
-7,22 $
Beta
0,41
Shares outstanding
139,02 млн
No. of employees
673
News stories
From web sources and news partners
AD HOC NEWS
·
6 сағат бұрын
Cytokinetics announces four HFSA presentations: 18 analysts rate Cytokinetics stock Buy
AD HOC NEWS
·
1 күн бұрын
Cytokinetics stock heads into four October heart presentations
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, Калифорния, Америка Құрама Штаттары
Sector-
Websitecytokinetics.com